Bridgewater, NJ, United States of America

Gilles C Bignan

This inventor holds 24 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 10 EPO patents. Top assignees: Janssen Pharmaceutica Nv, Janssen Biotech, Inc.. Active years: 2006-2023.

USPTO Granted Patents = 24 (Patent Applications = 12)

% Patents Active = 45.8

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 59(Granted Patents)

Location History:

Brigewater, NJ (US) (2013)
Bridgewater, NJ (US) (2006 - 2022)
Spring House, PA (US) (2023)

Company Filing History:

20 out of 2,099

Janssen Pharmaceutica Nv

patents

4 out of 433

Janssen Biotech, Inc.

patents

Years Active: 2006-2023

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11597746 - Cyclic dinucleotides as sting agonists (2023-03-07),

2. 11492367 - Cyclic dinucleotides as sting agonists (2022-11-08),

3. 11472830 - Cyclic dinucleotides as sting agonists (2022-10-18),

4. 11021511 - Cyclic dinucleotides as sting agonists (2021-06-01),

5. 10981926 - Substituted thiohydantoin derivatives as androgen receptor antagonists (2021-04-20),

6. 10501469 - Substituted thiohydantoin derivatives as androgen receptor antagonists (2019-12-10),

7. 10077261 - Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer (2018-09-18),

8. 10000502 - Substituted thiohydantoin derivatives as androgen receptor antagonists (2018-06-19),

9. 8796256 - Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators (2014-08-05),

10. 8778956 - Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders (2014-07-15),

11. 8741916 - 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor (2014-06-03),

12. 8685990 - Pyrimidine compounds as delta opioid receptor modulators (2014-04-01),

13. 8580832 - Substituted phenoxy aminothiazolones as estrogen related receptor-α modulators (2013-11-12),

14. 8513271 - Pyrimidine compounds as delta opioid receptor modulators (2013-08-20),

15. 8445690 - Aminothiazolones as estrogen related receptor-alpha modulators (2013-05-21),

Title: Inventor Gilles C Bignan - Revolutionizing Industries with Innovation

Introduction: Gilles C Bignan, a visionary inventor based in Bridgewater, NJ (US), is renowned for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: Gilles C Bignan holds several patents in the fields of renewable energy, sustainable technology, and advanced materials, showcasing his commitment to driving positive change through his inventions.

Career Highlights: With a career spanning over two decades, Gilles C Bignan has consistently pushed the boundaries of technological advancement, earning recognition for his pioneering work in enhancing efficiency and sustainability across different sectors.

Collaborations: Throughout his career, Gilles C Bignan has collaborated with leading research institutions, universities, and companies to bring his ideas to life, fostering a culture of innovation and excellence in the process.

Conclusion: In conclusion, Gilles C Bignan stands as a true innovator whose passion for creating a better future shines through in his remarkable inventions, leaving a lasting impact on the industries he touches.